EU
The EU has been early in conducting PV, and possesses a sound PV system which is also divided into three layers for regulation: directives, regulations, and guidelines. See the following table for the main establishment process of regulations of the EU PV system.

Table 1 Main Regulation Documents within Legal Framework of the EU PV System
|
Name |
Type |
Release time |
Released by |
Main content |
|
2001/83/EC |
Directive |
November 6, 2001 |
European Parliament (EP), Council of the European Union |
Chapter 9 details the content of PV |
|
726/2004/EC |
Regulation |
March 31, 2004 |
EP, Council of the European Union |
It lays down procedures for management of pharmaceutical product marketing approval and monitoring |
|
2004/27/EC |
Directive |
March 31, 2004 |
EP, Council of the European Union |
It raises higher requirements for the quality, safety, and effectiveness of pharmaceutical products for human use |
|
EudraLex: Pharmacovigilance guidance for human medicinal products (Volume 9A) |
Guideline |
March 2007 |
European Commission (EC) |
It laid down detailed provisions of the PV of the EU and was subsequently replaced by the good pharmacovigilance practice (GVP) |
|
1235/2010/EU |
Regulation |
December 15, 2010 |
EP, Council of the European Union |
It strengthens the safety monitoring of pharmaceutical products after marketing, and improves the risk-benefit balance of pharmaceutical products |
|
2010/84/EU |
Directive |
December 15, 2010 |
EP, Council of the European Union |
It strengthens the safety monitoring of pharmaceutical products after marketing, and improves the risk-benefit balance of pharmaceutical products |
|
520/2012/EU |
Regulation |
June 19, 2012 |
EC |
It is the detailed rules f... Read More
Related News
New FDA Regulations in the Year 2024
Muhammad Asim Niazi January 7, 2025
Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkins
firstwordpharma February 8, 2017
FDA Grants Fast Track Designation To Angionetics’ Generx Product Candidate, A One-Time Gene Therapy
firstwordpharma February 8, 2017 You may like
Oil Powder Bupleuri Radix P.E Bupleurum Sinensis Saikosapoins Chinese Thorowax Root Extract
Lamivudine USP Pharmaceutical Pharmaceutical API Antiviral drugs Nucleoside made in china
Methyl L-leucinate hydrochloride/L-Leucine methyl ester hydrochloride CAS: 7517-19-3
Milk Pasteurizer Tank Milk Powder Production Processing Machine Milk Pasteurization Equipment
Methyl L-isoleucinate hydrochloride/L-Isoleucine methyl ester hydrochloride CAS: 18598-74-8
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Nurah Ekhlaque
Sep 19, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
|










(All Rights Reserved)